Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-01-21 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2020-01-21 Huang Jane CMO, Hematology Sale −813 $170.09 $138K 687
2020-01-21 Huang Jane CMO, Hematology Sale −600 $171.27 $103K 87
2020-01-21 Huang Jane CMO, Hematology Sale −87 $172.34 $15K 0
2020-01-21 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 558,575
2019-12-17 OYLER JOHN Chief Executive Officer Sale −7,055 $158.63 $1.1M 55,204
2019-12-17 OYLER JOHN Chief Executive Officer Sale −15,466 $159.59 $2.5M 39,738
2019-12-17 OYLER JOHN Chief Executive Officer Sale −16,965 $160.60 $2.7M 22,773
2019-12-17 OYLER JOHN Chief Executive Officer Sale −18,215 $161.49 $2.9M 4,558
2019-12-17 OYLER JOHN Chief Executive Officer Sale −2,400 $162.42 $390K 2,158
2019-12-17 OYLER JOHN Chief Executive Officer Sale −200 $163.20 $33K 1,958
2019-12-17 OYLER JOHN Chief Executive Officer Sale −1,958 $165.61 $324K 0
2019-12-16 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2019-12-16 Huang Jane CMO, Hematology Sale −100 $160.07 $16K 1,400
2019-12-16 Huang Jane CMO, Hematology Sale −800 $161.93 $130K 600
2019-12-16 Huang Jane CMO, Hematology Sale −100 $165.55 $17K 500
2019-12-16 Huang Jane CMO, Hematology Sale −100 $168.90 $17K 400
2019-12-16 Huang Jane CMO, Hematology Sale −200 $170.73 $34K 200
2019-12-16 Huang Jane CMO, Hematology Sale −100 $172.13 $17K 100
2019-12-16 Huang Jane CMO, Hematology Sale −100 $173.59 $17K 0

Page 96 of 99 · 1,972 trades